Acorah Software Products - Accounts Production 16.4.675 false true false true No description of principal activity 23 April 2024 30 April 2025 30 April 2025 15672349 Dr Olivia Grant iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15672349 2024-04-22 15672349 2025-04-30 15672349 2024-04-23 2025-04-30 15672349 frs-core:CurrentFinancialInstruments 2025-04-30 15672349 frs-bus:PrivateLimitedCompanyLtd 2024-04-23 2025-04-30 15672349 frs-bus:FilletedAccounts 2024-04-23 2025-04-30 15672349 frs-bus:Micro-entities 2024-04-23 2025-04-30 15672349 frs-bus:AuditExempt-NoAccountantsReport 2024-04-23 2025-04-30 15672349 frs-bus:Director1 2024-04-23 2025-04-30
Registered number: 15672349
Agenomicsphd Limited
Unaudited Financial Statements
For the Period 23 April 2024 to 30 April 2025
Agenomicsphd Limited
Balance Sheet
As At 30 April 2025
Balance Sheet
Registered number: 15672349

| 30 April 2025
--- | ---
|  | £
Fixed assets |  | 2,162
Current assets |  | 25,040
Prepayments and accrued income |  | 12,197
Creditors: Amounts Falling Due Within One Year |  | (14,499 )
NET CURRENT ASSETS |  | 22,738
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 24,900
NET ASSETS |  | 24,900
CAPITAL AND RESERVES |  | 24,900

## Notes

1. General Information
Agenomicsphd Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15672349 . The registered office is Belmont Suite, Paragon Business Park, Chorley New Road, Bolton, BL6 6HG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Olivia Grant Director
13/10/2025